ClinicalTrials.gg
Sign In

Telangiectasis clinical trials

The registry lists 69 studies for Telangiectasis across more than 10 countries. 12 are recruiting or about to start. 38 of them are mainly about Telangiectasis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 2 narrower conditions too, such as Telangiectasia, Hereditary Hemorrhagic: 209 studies, 40 open.

Get an email when these change. Save the Telangiectasis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
47
Recruiting
9
Status unknown
5
Not yet recruiting
3
Withdrawn
2
Terminated
2

Phase

Phase 2
13
Phase 1
8
Phase 4
8
Phase 3
7
Early Phase 1
1

Where

United States
33
Brazil
10
Australia
9
United Kingdom
5
Denmark
4
France
4

Who runs them

Neurotech Pharmaceuticals (7) · National Eye Institute (NEI) (3) · The Lowy Medical Research Institute Limited (3) · Cutera Inc. (3) · University of Sao Paulo (3) · Johns Hopkins University (2) · Alma Lasers Inc. (2) · UPECLIN HC FM Botucatu Unesp (2)

What is being tested here

Drugs under test in Telangiectasis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Nicotinamide-beta-riboside101
Ranibizumab004
Brimonidine002
Sirolimus001
Calcium Dobesilate001
Glucose001
Polidocanol001
Baclofen001
Apremilast001
Bevacizumab011

Drug classes tested here Angiogenesis inhibitors 5

Coming up

2phase 3 studies under way
5studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 5

Who these studies take

Of the 9 Telangiectasis studies recruiting now, 5 (56%) set no upper age limit and 3 (33%) stop at 75 or younger. 1 (11%) take children under 18. 3 (33%) are for women only and 0 (0%) for men only; 3 (33%) take healthy volunteers.

Recruiting studies that take each age, of 9
AgeWomenMen
101 (11%)1 (11%)
186 (67%)5 (56%)
307 (78%)6 (67%)
408 (89%)6 (67%)
508 (89%)6 (67%)
657 (78%)5 (56%)
756 (67%)5 (56%)
855 (56%)4 (44%)

Across all 69 studies, recruiting or not: 28% stop at 75 or younger and 19% at 65; 17% take children; 13% are for women only and 1% for men only; 25% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Telangiectasis studies take

Of 14 interventional studies with no phase under Telangiectasis, half reached primary completion within 23 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase23 mo8–27 · 14 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Started recruiting1

Studies

Recruiting first, then most recently updated. Showing 50 of 69. Browse all 69 → or search them.